Nachrichten zur Becton Dickinson & Co. Aktie

Becton Dickinson ist in der Entwicklung, Herstellung und dem Vertrieb von medizinischen Geräten, Laborausrüstung und Diagnostikprodukten tätig. Mit über 70.000…

Insiders have been trading these 5 stocks: (($BDX)), (($BK)), (($INCY)), (($DUOL)) and (($JBL)). Here is a breakdown of their recent…

Waters Corp will buy a unit spun off from medtech provider Becton Dickinson in a stock-and-cash transaction valued at $17.5…

Becton Dickinson at Goldman Sachs Conference: Strategic Moves Ahead…

Becton, Dickinson and Co. (NYSE:BDX) develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The 52-week…

Medical device maker Becton Dickinson cuts 2025 profit forecast on potential tariff hit…

…

Activist Starboard took a position in Becton Dickinson, calling for the company to sell its life sciences business. The company…

While the top- and bottom-line numbers for Becton Dickinson (BDX) give a sense of how the business performed in the…

Becton Dickinson (BDX) delivered earnings and revenue surprises of 15.10% and 1.32%, respectively, for the quarter ended December 2024. Do…

…

Becton Dickinson settles charges over infusion pump risks, SEC says…

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

…

According to a research report published by Exactitude Consultancy, Companies covered:Abbott Laboratories Inc. - North America, Agilent Technologies Inc. -…

The Global Breast Biopsy Devices Market Size was Valued at USD 1.7 Billion in 2023 and the Worldwide Breast Biopsy…

Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinsons plan to buy a key division for $4.2 billion.…

Becton Dickinson earnings beat by $0.20, revenue topped estimates…

Becton Dickinson stock target raised on strong product demand…

Becton Dickinson exec sells over $67k in company stock…

LOS ANGELES--(BUSINESS WIRE)--Die AIDS Healthcare Foundation (AHF) fordert die Weltgesundheitsorganisation (WHO) auf, die Hersteller von lebenswichtigen Point-of-Care (POC) CD4-Geräten, darunter…